5 Year Outcomes after Proton Therapy for Treatment of High-Risk Neuroblastoma (HR-NBL)

被引：0
|
作者：
Hill-Kayser, C. [1 ,2 ]
Balamuth, N. [3 ]
Womer, R. [3 ]
Maris, J. [3 ]
Mosse, Y. [3 ]
Fox, E. [3 ]
Balis, F. [3 ]
Grupp, S. [3 ]
Miller, A. [3 ]
Kurtz, G. [1 ,2 ]
Lustig, R. [1 ,2 ]
Tochner, Z. [1 ,2 ]
Bagatell, R. [3 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Radiat Oncol, Philadelphia, PA USA
[3] Childrens Hosp Philadelphia, Oncol, Philadelphia, PA 19104 USA
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-088
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [21] Survival and Local Recurrence Risk in Patients with High-Risk Neuroblastoma Treated with Proton Therapy over a 10 Year Interval
    Hill-Kayser, C. E.
    Li, Y.
    Kurtz, G.
    Mattei, P.
    Balis, F.
    Lustig, R. A.
    LaRiviere, M. J.
    MacFarland, S.
    Batra, V.
    Mosse, Y.
    Maris, J.
    Balamuth, N.
    Bagatell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E516 - E517
  • [22] Relapse in the skull after myeloablative therapy for high-risk neuroblastoma
    Sangthawan, D
    DesRosiers, PM
    Randall, ME
    Robertson, K
    Goebel, S
    Fallon, R
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20 (01) : 23 - 30
  • [23] Patterns of Recurrence after Radiation Therapy for High-risk Neuroblastoma
    Jo, J. H.
    Ahn, S. D.
    Choi, E. K.
    Kim, J. H.
    Lee, S. W.
    Song, S. Y.
    Yoon, S. M.
    Kim, Y. S.
    Park, J. H.
    Kim, S. S.
    Jung, J. H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S883 - S883
  • [24] Patterns of recurrence after radiation therapy for high-risk neuroblastoma
    Jo, Ji Hwan
    Do Ahn, Seung
    Koh, Minji
    Kim, Jong Hoon
    Lee, Sang-wook
    Song, Si Yeol
    Yoon, Sang Min
    Kim, Young Seok
    Kim, Su Ssan
    Park, Jin-hong
    Jung, Jinhong
    Choi, Eun Kyung
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 224 - 231
  • [25] Proton Radiotherapy for High-Risk Pediatric Neuroblastoma: Early Outcomes and Dose Comparison
    Hattangadi, Jona A.
    Rombi, Barbara
    Yock, Torunn I.
    Broussard, George
    Friedmann, Alison M.
    Huang, Mary
    Chen, Yen-Lin E.
    Lu, Hsiao-Ming
    Kooy, Hanne
    MacDonald, Shannon M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 1015 - 1022
  • [26] MAJOR RESULTS FROM THE HR-NBL1/SIOPEN TRIAL FOR HIGH RISK NEUROBLASTOMA
    Ladenstein, Ruth
    Poetschger, Ulrike
    Luksch, Roberto
    Brock, Penelope
    Castel, Victoria
    Yaniv, Isaac
    Papadakis, Vassilios
    Laureys, Genevieve
    Malis, Josef
    Balwierz, Walentyna
    Ruud, Ellen
    Kogner, Per
    Schroeder, Henrik
    De Lacerda, Ana Forjaz
    Beck-Popovic, Maja
    Bician, Pavel
    Garami, Miklos
    Trahair, Toby
    Ambros, Peter
    Pearson, Andrew D. J.
    Valteau-Couanet, Dominique
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 988 - 989
  • [27] RISK FACTORS IN HIGH RISK NEUROBLASTOMA PATIENTS OVER 5 YEARS: RESULTS FROM THE HR-NBL1/SIOPEN TRIAL
    Ladenstein, Ruth
    Valteau-Couanet, Dominique
    Elliott, Martin
    Luksch, Roberto
    Castel, Victoria
    Ash, Shifra
    Balwierz, Walentyna
    Laureys, Genevieve
    Beiske, Klaus
    Kogner, Per
    Papadakis, Vassilios
    Beck-Popovic, Maja
    Malis, Josef
    Brok, Jesper Sune
    Vettenranta, Kim
    Bician, Pavel
    Trahair, Toby
    Chan, Godfrey Chi Fung
    Owens, Cormac
    Lacerda, Ana
    Sarnacki, Sabine
    Boterberg, Tom
    Taschner-Mandl, Sabine
    Schleiermacher, Gudrun
    Lode, Holger
    Poetschger, Ulrike
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [28] Success of the HR-NBL1/SIOPEN Trial Local Control Strategy in High-Risk Neuroblastoma Patients Receiving High-Dose Therapy and Stem Cell Transplantation
    Ladenstein, R.
    Poetschger, U.
    Boterberg, T.
    Dieckmann, K.
    Bolle, S.
    Holmes, K.
    Sarnacki, S.
    Gomez-Chacon, J.
    Brock, P.
    Luksch, R.
    Ash, S.
    Balwierz, W.
    Ruud, E.
    Papadakis, V.
    Owens, C.
    Stenman, J.
    Schroeder, H.
    Trahair, T.
    Valteau-Couanet, D.
    Gaze, M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S261 - S262
  • [29] Retinoid therapy of high-risk neuroblastoma
    Reynolds, CP
    Matthay, KK
    Villablanca, JG
    Maurer, BJ
    CANCER LETTERS, 2003, 197 (1-2) : 185 - 192
  • [30] HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution
    Fong, Abraham
    Park, Julie R.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (08) : 539 - 548
12345